Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Collaborative Network to Take Responsibility for Oral Anticancer Therapy
- Status
- UNKNOWN
- Phase
- NA
Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check Partners
- Status
- COMPLETED
- Phase
- NA
Yervoy Pregnancy Surveillance Study
- Status
- WITHDRAWN
- Phase
- N/A
Tracing Dissemination of Melanoma Cells in Healthy Tissues
- Status
- COMPLETED
- Phase
- N/A
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
- Status
- COMPLETED
- Phase
- N/A
Family Lifestyle Actions and Risk Education Study
- Status
- COMPLETED
- Phase
- NA
Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Anti-telomerase T CD4 Immunity in Melanoma
- Status
- UNKNOWN
- Phase
- NA
Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Bio-marker Analysis Using Circulating Tumor Cells in Patients With Melanoma
- Status
- WITHDRAWN
- Phase
- N/A
X4P-001 and Pembrolizumab in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Dose-seeking Study of Pembrolizumab Plus Vemurafenib and Cobimetinib Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2